BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 17293908)

  • 21. Pregnancy outcomes of women with HIV in a district general hospital in the UK.
    Carey L; Desouza C; Moorcroft A; Elgalib A
    J Obstet Gynaecol; 2018 Aug; 38(6):777-780. PubMed ID: 29526132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low rate of mother-to-child transmission of HIV-1 after nevirapine intervention in a pilot public health program in Yaoundé, Cameroon.
    Ayouba A; Tene G; Cunin P; Foupouapouognigni Y; Menu E; Kfutwah A; Thonnon J; Scarlatti G; Monny-Lobé M; Eteki N; Kouanfack C; Tardy M; Leke R; Nkam M; Nlend AE; Barré-Sinoussi F; Martin PM; Nerrienet E;
    J Acquir Immune Defic Syndr; 2003 Nov; 34(3):274-80. PubMed ID: 14600571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006.
    Townsend CL; Cortina-Borja M; Peckham CS; de Ruiter A; Lyall H; Tookey PA
    AIDS; 2008 May; 22(8):973-81. PubMed ID: 18453857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low detectable postpartum viral load is associated with HIV transmission in Malawi's prevention of mother-to-child transmission programme.
    Landes M; van Lettow M; Nkhoma E; Tippett Barr B; Truwah Z; Shouten E; Jahn A; Auld A; Kalua T; van Oosterhout JJ
    J Int AIDS Soc; 2019 Jun; 22(6):e25290. PubMed ID: 31180186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug resistance among HIV-infected pregnant women receiving antiretrovirals for prophylaxis.
    Duran AS; Losso MH; Salomón H; Harris DR; Pampuro S; Soto-Ramirez LE; Duarte G; de Souza RS; Read JS;
    AIDS; 2007 Jan; 21(2):199-205. PubMed ID: 17197811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. National-level effectiveness of ART to prevent early mother to child transmission of HIV in Namibia.
    Agabu A; Baughman AL; Fischer-Walker C; de Klerk M; Mutenda N; Rusberg F; Diergaardt D; Pentikainen N; Sawadogo S; Agolory S; Dinh TH
    PLoS One; 2020; 15(11):e0233341. PubMed ID: 33170840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception.
    Mandelbrot L; Tubiana R; Le Chenadec J; Dollfus C; Faye A; Pannier E; Matheron S; Khuong MA; Garrait V; Reliquet V; Devidas A; Berrebi A; Allisy C; Elleau C; Arvieux C; Rouzioux C; Warszawski J; Blanche S;
    Clin Infect Dis; 2015 Dec; 61(11):1715-25. PubMed ID: 26197844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zinc supplementation to HIV-1-infected pregnant women: effects on maternal anthropometry, viral load, and early mother-to-child transmission.
    Villamor E; Aboud S; Koulinska IN; Kupka R; Urassa W; Chaplin B; Msamanga G; Fawzi WW
    Eur J Clin Nutr; 2006 Jul; 60(7):862-9. PubMed ID: 16452912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is peripartum zidovudine absolutely necessary for patients with a viral load less than 1,000 copies/ml?
    Wong VV
    J Obstet Gynaecol; 2011 Nov; 31(8):740-2. PubMed ID: 22085066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
    Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
    BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is the interruption of antiretroviral treatment during pregnancy an additional major risk factor for mother-to-child transmission of HIV type 1?
    Galli L; Puliti D; Chiappini E; Gabiano C; Ferraris G; Mignone F; Viganò A; Giaquinto C; Genovese O; Anzidei G; Badolato R; Buffolano W; Maccabruni A; Salvini F; Cellini M; Ruggeri M; Manzionna M; Bernardi S; Tovo P; de Martino M;
    Clin Infect Dis; 2009 May; 48(9):1310-7. PubMed ID: 19309307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV-1 mother-to-child transmission and drug resistance among Brazilian pregnant women with high access to diagnosis and prophylactic measures.
    Alcântara KC; Lins JB; Albuquerque M; Aires LM; Cardoso LP; Minuzzi AL; Stefani MM
    J Clin Virol; 2012 May; 54(1):15-20. PubMed ID: 22317908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimizing prevention of HIV mother to child transmission: Duration of antiretroviral therapy and viral suppression at delivery among pregnant Malawian women.
    Chagomerana MB; Miller WC; Tang JH; Hoffman IF; Mthiko BC; Phulusa J; John M; Jumbe A; Hosseinipour MC
    PLoS One; 2018; 13(4):e0195033. PubMed ID: 29614083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of plasma viral-load monitoring and the prevention of mother-to-child transmission of HIV-1 in three health facilities of the Littoral region of Cameroon.
    Kafack EVF; Fokam J; Nana TN; Saniotis A; Halle-Ekane GE
    PLoS One; 2022; 17(11):e0277271. PubMed ID: 36342923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of early and late mother-to-child transmission of HIV in a breastfeeding population: HIV Network for Prevention Trials 012 experience, Kampala, Uganda.
    Mmiro FA; Aizire J; Mwatha AK; Eshleman SH; Donnell D; Fowler MG; Nakabiito C; Musoke PM; Jackson JB; Guay LA
    J Acquir Immune Defic Syndr; 2009 Sep; 52(1):32-9. PubMed ID: 19617849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of human immunodeficiency virus-infected pregnant women at Latin American and Caribbean sites.
    Read JS; Cahn P; Losso M; Pinto J; Joao E; Duarte G; Cardoso E; Freimanis-Hance L; Stoszek SK;
    Obstet Gynecol; 2007 Jun; 109(6):1358-67. PubMed ID: 17540808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mother-to-child transmission of human immunodeficiency virus in aten years period.
    Delicio AM; Milanez H; Amaral E; Morais SS; Lajos GJ; e Silva JL; Cecatti JG
    Reprod Health; 2011 Nov; 8():35. PubMed ID: 22129112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-term antiretroviral therapy to prevent mother-to-child transmission is safe and results in a sustained increase in CD4 T-cell counts in HIV-1-infected mothers.
    Palacios R; Senise J; Vaz M; Diaz R; Castelo A
    HIV Med; 2009 Mar; 10(3):157-62. PubMed ID: 19245537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-infected adolescent mothers and their infants: low coverage of HIV services and high risk of HIV transmission in KwaZulu-Natal, South Africa.
    Horwood C; Butler LM; Haskins L; Phakathi S; Rollins N
    PLoS One; 2013; 8(9):e74568. PubMed ID: 24073215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contribution of different antiretroviral regimens containing zidovudine, lamivudine and ritonavir-boosted lopinavir on HIV viral load reduction during pregnancy.
    Sripan P; Le Coeur S; Ingsrisawang L; Cressey TR; Bouazza N; Foissac F; Ngo-Giang-Huong N; Traisathit P; Srirompotong U; Ayudhaya OP; Puangsombat A; Jungpipun J; Jittayanun K; Tréluyer JM; Jourdain G; Lallemant M; Urien S
    Antivir Ther; 2016; 21(5):435-40. PubMed ID: 26492107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.